SYSTEM FOR MONITORING NEURODEGENERATIVE DISORDERS THROUGH ASSESSMENTS IN DAILY LIFE SETTINGS THAT COMBINE BOTH NON-MOTOR AND MOTOR FACTORS IN ITS DETERMINATION OF THE DISEASE STATE
20220378297 · 2022-12-01
Assignee
Inventors
Cpc classification
G16H20/70
PHYSICS
A61B5/165
HUMAN NECESSITIES
G16H50/20
PHYSICS
G16H50/30
PHYSICS
A61B5/4088
HUMAN NECESSITIES
A61B5/4082
HUMAN NECESSITIES
A61B5/02438
HUMAN NECESSITIES
G16H50/70
PHYSICS
A61B5/4809
HUMAN NECESSITIES
A61B5/0205
HUMAN NECESSITIES
International classification
A61B5/0205
HUMAN NECESSITIES
A61B5/00
HUMAN NECESSITIES
A61B5/11
HUMAN NECESSITIES
Abstract
The method of the present invention quantifies the severity of a subject's neurodegenerative disorder. The subject answers a questionnaire which results in a patient-reported outcome dataset. Benchmark tests are carried out by the subject performing one or more tasks resulting in a task result dataset. Continuous sensors collect data resulting in a sensor dataset. Short assessment tests of the subject are conducted resulting in a short assessment dataset. The patient-reported outcome dataset, task result dataset, sensor dataset, and short assessment dataset are aggregated into an output dataset that includes non-motor outcome measures and motor outcome measures. A single score is generated that quantifies the severity of a neurodegenerative disorder of the subject based on the output dataset.
Claims
1. A method for quantifying the severity of a subject's neurodegenerative disorder, comprising the steps of: providing a subjective questionnaire to a subject, the answers to which resulting in a patient-reported outcome dataset; performing a benchmark test of the subject by the subject performing a task resulting in a task result dataset; providing a device to a subject, the device including at least one sensor configured and arranged for continuous sensing at least one parameter of the subject and/or an environmental condition proximal to the subject; collecting data sensed by the at least one sensor resulting in a sensor dataset; conducting a short assessment test of the subject resulting in a short assessment dataset; aggregating the patient-reported outcome dataset, task result dataset, sensor dataset, and short assessment dataset into an output dataset including non-motor outcome measures and motor outcome measures; and generating a single score quantifying the severity of a neurodegenerative disorder of the subject based on the output dataset.
2. The method of claim 1, wherein the at least one parameter is active energy burned, heart rate, body temperature, resting heart rate, respiratory rate, steps, walking heart rate, distance walking/running, flights climbed, elevation gain, minutes moved, distance changes, sleep durations, exercise time, high/low heart rate events, heart rate variability, point/path variability, response times, completion rates and accuracies in task completion.
3. The method of claim 1, wherein the environmental condition is ambient temperature, weather, imagery, and social.
4. The method of claim 1, wherein the sensor is a wearable sensor.
5. The method of claim 1, wherein the sensor is an ambient sensor.
6. The method of claim 1, wherein the task is directed to shapes, contours, patterns, shading, hue, color, brightness, degrees of freedom, visibility, language, speed, tone, voice, repetition, timing, brevity.
7. The method of claim 1, wherein the non-motor outcome measures and motor outcome measures are derived from informational components selected from the group consisting of: cognitive, emotional, behavioral, and physical.
8. The method of claim 1, wherein the non-motor outcome measures are derived from at least one of the domains of attention, computation, executive function, learning/memory, orientation, language, processing speed, and non-motor aspects of experiences of daily living.
9. The method of claim 1, wherein the motor outcome measures are derived from at least one of the domains of motor aspects of experiences of daily living, motor examination, and motor complications.
Description
BRIEF DESCRIPTION OF THE DRAWING FIGURES
[0018] The novel features which are characteristic of the present invention are set forth in the appended claims. However, the invention's preferred embodiments, together with further objects and attendant advantages, will be best understood by reference to the following detailed description taken in connection with the accompanying drawings in which:
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
[0027] Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the device and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the present invention is defined solely by the claims. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present disclosure. Further, in the present disclosure, like-numbered components of the embodiments generally have similar features, and thus within a particular embodiment each feature of each like-numbered component is not necessarily fully elaborated upon. Additionally, to the extent that linear or circular dimensions are used in the description of the disclosed systems, devices, and methods, such dimensions are not intended to limit the types of shapes that can be used in conjunction with such systems, devices, and methods. A person skilled in the art will recognize that an equivalent to such linear and circular dimensions can easily be determined for any geometric shape. Further, to the extent that directional terms like proximal, distal, top, bottom, up, or down are used, they are not intended to limit the systems, devices, and methods disclosed herein. A person skilled in the art will recognize that these terms are merely relative to the system and device being discussed and are not universal. The present invention is related to monitoring neurodegenerative disorders and diseases, such as Parkinson's disease, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), motor neuron disease, ataxia, multiple system atrophy (MSA), and other disorders and diseases. Further, for ease of discussion and by way of example, the present invention is discussed in detail herein in connection with Parkinson's disease but it should be understood that the present invention is not limited to Parkinson's disease and has applicability in any other disease or disorder.
[0028] In general, the invention enables capacity, performance, and perception elements of an individual's health to be measured through a combination of subjective measures derived from the individual, capacity measures derived from the wearables 34, as in
[0029] The system and method of the present invention provided a Patient-Centered Digital Health Platform 10 for Patient-Reported Outcomes (PROs) and Symptom Diary to address various wellness concerns 12, as shown in
[0030] The wellness concerns 12 involve non-motor 14 and motor 16 elements. As seen in
[0031] As seen in
[0032] The tasks 26 performed in accordance with the present invention can be to assess attention, computation, executive function, learning/memory, orientation, language, processing speed, digit span, and the like. Thus, the platform 10 can include questionnaires 28, ambient sensors 30, which may be of the nature of GPS 32 and wearables 34, for example, as shown in
[0033] Turning now to
[0034] Questionnaires 28 via Patient-Reported Outcomes (PRO) are seen in
[0035] More specifically, an Edge/Mobile Computing based Symptom Tracking Analytics services are preferably employed on a mobile phone thereby reducing the challenges of patient data privacy and security. Moreover, an interoperable PRO Bank, a centralized database running on a secure server, is preferably used. The digital platform 10 of the present invention preferably will query the PRO domain based on the context derived from the wearable data analytics. Billable, reimbursable digital health PRO services for doctors to make clinical decisions is also possible.
[0036] Because Parkinson's Disease affects uniquely to each patient, there currently exist many approved PROs including but not limited to NIH Toolbox, PDQ-39, PDQ-8, and PROMIS29. Since it may be challenging to settle on a single PRO module to have a comprehensive understanding of a patient's experiences, management of such a clinical decision is possible with the present invention. For example, it is possible to link PROs to electronic health records (EHRs) and generate specific end-points to achieve improved quality of care for improved patient satisfaction for increased revenue. The integration of PROs with an EHR system will enhance adherence and monitoring with prescribable digital health services.
[0037] Still further, the system and method 10 of the present invention may deploy disease-specific education from PRO and symptom tracking using trusted resources for disease and symptom-specific education. Since patients with Parkinson's Disease face a variety of symptoms and experiences for which they have limited understanding, the present invention 10 can develop a collective knowledge base from reliable resources and can offer PRO guided education via the present invention.
[0038] Schedulable micro-assessments 40, as seen in
[0039] More specifically, the present invention 10 further provides a new and novel system to monitor neurodegenerative disorders and diseases through assessments in daily life settings that uniquely combines both non-motor and motor factors in its determination of the disease state. Such a combination of non-motor factors 14 and motor factors 16 for the determination of the disease state is not found in the prior art.
[0040] Referring now to
[0041] Also, the assigned and completed tasks 26 can be driven by prior knowledge of the user and or other task managers. The users of the system and method 10 of the present invention may include the patient with the disorder, the caregiver 44 or partner of the patient, and the overall health care team.
[0042] In accordance with the present invention, a given task 26 for benchmark assessment may include various individual components, such as 1) Items—which may include variation in shapes/contours/patterns/shading/hue/color/brightness of, for example, icons or other visuals presented; 2) Pathways—which may include variation such as in contour/degrees of freedom/visibility; 3) Instructions—which include variation in language/speed/tone/repetition/timing/brevity; and 4) Data Sources—which is collected from the patient 49 with the disorder or disease, the caregiver 44 or partner, the healthcare team 46, and/or ambient sensors, such as mobile, positioning or wearable devices.
[0043] Referring back to
[0044] The structure of the components involved in a given task 26 may also include data streams (such as from sensors, including ambient sensors and user engagement with a given interfaces, such as those of a digital device in the form of a tablet, or the like) of parameters such as active energy burned, heart rate, body temperature, resting heart rate, respiratory rate, steps, walking heart rate, distance walking/running, flights climbed, elevation gain, minutes moved, distance changes, sleep durations, exercise time, high/low heart rate events, heart rate variability, point/path variability, response times, completion rates, accuracies in task completion, and the like. The completion of a given task 26 by the patient 49 provides outcome measures that are used to determine the overall state of the given disorder or disease, as represented by a single score 42.
[0045] More specifically, in accordance with the system and method of the present invention, the knowledge for the non-motor 14 and motor 16 outcome measures are derived from informational components such as: 1) Cognitive 18—Attention, computation, executive functioning, learning/memory, orientation, language, processing speed and digit span; 2) Emotional 20—Anxiety, depression, apathy, fatigue, quality of life; 3) Behavioral 24—Activities of daily living, Sleep, Social, Intellectual; and 4) Physical 22—Gastrointestinal, urinary, mood, pain, fatigue, speech/swallowing and activities of daily living, tremor, kinesia, rigidity, hand-eye coordination, gait/stability, and freezing.
[0046] Tasks 26 are assessed through measures to score a unique daily function through the discovery and analysis through a combination of various elements.
[0047] Trusted third-party observations are employed to derive a measure of maximal effort or benchmarks, enabling prior observations may provide an initial baseline measure. These third-party observations may be made by clinical, digital, or by other fashion.
[0048] A measure of perceived ability (perception) 48, as seen in flowchart map of
[0049] Referring again to
[0050] In another example, as shown in
[0051] In another example, in
[0052]
[0053] Also,
[0054] Still further,
[0055] A measure of active daily living is derived from wearable/environmental/social datasets about mobility, health and wellness of the patient. For example, any device 34 may be used for this purpose, such as a smart watch, smart phone, activity tracker, and the like, as shown in
[0056] In view of the foregoing, the method of the present invention quantifies the severity of a subject's neurodegenerative disorder. Questionnaires, benchmark tests are carried out and sensors are used for continuous monitoring. Short assessment tests of the subject are conducted. The data collected, which includes non-motor outcome measures and motor outcome measures from the foregoing are aggregated to arrive at a single score that quantifies the severity of a neurodegenerative disorder of the subject based on the output dataset.
[0057] For example, the qualification of scoring is a process of information mining via the statistical inference and the intercorrelation of the data acquired from the various sources including task performance on the digital interface, questionnaires, and sensor data. The scoring algorithm consists of a set of mathematical functions and models for signal processing, machine learning and AI, allowing to measure the disease state of patients with neurodegenerative disorder in single and multiple domains including motor and non-motor. The machine learning model is trained over time using the received data from different sources and used for the longitudinal monitoring of the disease state in daily life settings. The score is a measure of performance, perception, and capacity from the acquired data that are not only limited to the patients themselves but also caregivers/carepartners and clinicians. The correlation of the data from patients, caregivers, and clinicians is a part of the scoring process as it gives a deeper insight on the disease state of patients. For example, the mathematical functions that can be used for the scoring model of the present invention include normalization; detrending; principal component analysis; maximum likelihood estimators for the domains; match filtering is used based off of the domain variance, means, frequencies and powers are characteristics used in the match filtering; inter correlation or covariance used in ensuring the signals are properly decoupled; and the like.
[0058] It would be appreciated by those skilled in the art that various changes and modifications can be made to the illustrated embodiments without departing from the spirit of the present invention. All such modifications and changes are intended to be covered by the appended claims.